Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Stuart Patton currently holds 254,876 shares of HALOZYME THERAPEUTICS INC (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Stuart Patton has been a net seller of HALO stock. They have purchased $0 and sold $5.9M worth of shares.
John Stuart Patton's most recent insider trade was on Aug 19, 2014, when they sold 75,000 shares at $2.05 per share.
John Stuart Patton serves as Executive at HALOZYME THERAPEUTICS INC (HALO). They have executed 412 insider transactions totaling $5.9M over their tenure at the company.
John Stuart Patton holds the position of Executive at HALOZYME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
John Stuart Patton has shown a selling trading pattern, with $0 in total purchases and $5.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Stuart Patton was on Aug 19, 2014, when they sold $747.0K worth of HALO shares. This transaction involved 75,000 shares at $9.96 per share.
John Stuart Patton currently owns 254,876 shares of HALOZYME THERAPEUTICS INC (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Stuart Patton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Stuart Patton has 412 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS INC.
Set alerts for John Stuart Patton and 40,000+ other insiders.